Congenital heart disease: current indications for antithrombotic therapy in pediatric patients.

Reller, M D

Reller, M D.

Affiliation

Reller MD; Division of Pediatric Cardiology, Oregon Health Sciences University, 707 SW Gaines Road, CDRC-P, Portland, OR 97201, USA. rellerm@ohsu.edu

Curr Cardiol Rep ; 3(1): 90-5, 2001 Jan.

Article in En | MEDLINE | ID: mdl-11139805

Subject(s)

Anticoagulants/therapeutic use; Heart Defects, Congenital/complications; Platelet Aggregation Inhibitors/therapeutic use; Thrombosis/etiology; Thrombosis/prevention & control; Child; Dipyridamole/therapeutic use; Fontan Procedure; Heart Defects, Congenital/surgery; Heart Valve Prosthesis; Heparin/therapeutic use; Heparin, Low-Molecular-Weight/therapeutic use; Humans; Warfarin/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Platelet Aggregation Inhibitors / Heart Defects, Congenital / Anticoagulants Type of study: Guideline Limits: Child / Humans Language: En Journal: Curr Cardiol Rep Journal subject: CARDIOLOGIA Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links